Pfizer Stocks List
Related Industries:
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XMMD | A | db x-trackers MSCI Emerging Markets Index UCITS ETF | 5.31 | |
XMEM | A | db x-trackers MSCI Emerging Markets Index UCITS ETF | 5.31 | |
CAVE | F | VanEck Smart Home Active UCITS ETF A USD Acc | 3.21 | |
CVGB | D | VanEck Smart Home Active UCITS ETF A USD Acc GBP | 3.17 | |
XLPE | B | db x-trackers LPX MM® Private Equity UCITS ETF | 2.63 |
Compare ETFs
- Pfizer
Pfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($37 billion in 2022 revenues), Nirmatrelvir/ritonavir ($18 billion in 2022 revenues), Apixaban ($6 billion in 2022 revenues), a pneumococcal conjugate vaccine ($6 billion in 2022 revenues), and Palbociclib ($5 billion in 2022 revenues). In 2022, 42% of the company's revenues came from the United States, 8% came from Japan, and 50% came from other countries.Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020. The company ranks 43rd on the Fortune 500 and 43rd on the Forbes Global 2000.
Popular Now
Recent Comments
- TraderMike on Trades of the Week: Jan 8 - Jan 12, 2024
- Magneto296 on Trades of the Week: Jan 8 - Jan 12, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
From the Blog
Featured Articles